Shares in Swedish microcap stock Nanexa more than doubled after the drug-delivery group revealed a licensing deal with European pharma giant Novo Nordisk.
Market Samachar is a news aggregator. This article was originally published by CNBC. Tap the button above to read the full story on their site.